留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

硝基酪氨酸在糖尿病肾病中的病理作用

李红瑜 陈绮雁 刘丹阳 龙海波 许兆忠

李红瑜, 陈绮雁, 刘丹阳, 龙海波, 许兆忠. 硝基酪氨酸在糖尿病肾病中的病理作用[J]. 分子影像学杂志, 2014, 37(4): 264-267. doi: 10.3969/j.issn.1674-4500.2014.04.15
引用本文: 李红瑜, 陈绮雁, 刘丹阳, 龙海波, 许兆忠. 硝基酪氨酸在糖尿病肾病中的病理作用[J]. 分子影像学杂志, 2014, 37(4): 264-267. doi: 10.3969/j.issn.1674-4500.2014.04.15
Hongyu LI, Qiyan CHEN, Danyang LIU, Haibo LONG, Zhaozhong XU. Roles of nitrotyrosine in diabetic nephropathy[J]. Journal of Molecular Imaging, 2014, 37(4): 264-267. doi: 10.3969/j.issn.1674-4500.2014.04.15
Citation: Hongyu LI, Qiyan CHEN, Danyang LIU, Haibo LONG, Zhaozhong XU. Roles of nitrotyrosine in diabetic nephropathy[J]. Journal of Molecular Imaging, 2014, 37(4): 264-267. doi: 10.3969/j.issn.1674-4500.2014.04.15

硝基酪氨酸在糖尿病肾病中的病理作用

doi: 10.3969/j.issn.1674-4500.2014.04.15
详细信息
    作者简介:

    李红瑜,在读本科生,E-mail:fishingbaby@foxmail.com

    通讯作者:

    龙海波,主任医师,教授,电话:020-62782305,E-mail:longhb1966@163.com

Roles of nitrotyrosine in diabetic nephropathy

  • 摘要: 硝基酪氨酸被认为是体内氧化应激的标志物,可用于指导糖尿病及其并发症的临床诊断及治疗。而最近的研究表明,硝基酪氨酸不仅是糖尿病时的代谢产物及糖尿病慢性并发症的风险预测因子,本身还具有病理生理学活性。本文就硝基酪氨酸的生成、病理作用及其在糖尿病肾病发生、发展中的作用作一综述。

     

  • [1] Ceriello A, Piconi L, Esposito K, et al. Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes[J]. Diabetes Care, 2007, 30(7): 1694-8. doi: 10.2337/dc07-0318
    [2] Zhang HM, Dang H, Kamat A, et al. Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes[J]. PLoS One, 2012, 7: e32746. doi: 10.1371/journal.pone.0032746
    [3] Chi Q, Wang T, Huang K. Effect of insulin nitration by peroxynitrite on its biological activity[J]. Biochem Biophys Res Commun, 2005, 330(3): 791-6. doi: 10.1016/j.bbrc.2005.03.034
    [4] 马邵, 武传龙. 2型糖尿病患者血清3-硝基酪氨酸的检测及其意义[J]. 临床检验杂志, 2009, 4(4): 308-9. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGSQ201234265.htm
    [5] Turko IV, Murad F. Protein nitration in cardiovascular diseases[J]. Pharmacol Rev, 2002(54): 619-34.
    [6] Pietraforte D, Minetti M. Direct ESR detection or peroxynitrite-induced tyrosine-centred protein radicals in human blood plasma[J]. Biochem J, 1997, 325(3): 675-84. doi: 10.1042/bj3250675
    [7] Peluffo H, Shacka JJ, Ricart K, et al. Induction of motor neuron apoptosis by free 3-nitro-L-tyrosine[J]. J Neurochem, 2004, 89(3): 602-12. doi: 10.1046/j.1471-4159.2004.02363.x
    [8] Chang W, Webster DR, Salam AA, et al. Alteration of the C-terminal amino acid of tubulin specifically inhibits myogenic differentiation[J]. J Biol Chem, 2002, 277(34): 30690-8. doi: 10.1074/jbc.M204930200
    [9] van der Vliet A, Eiserich JP, Halliwell B, et al. Formation of reactive Nitrogen species during peroxidase-catalyzed oxidation of nitrite[J]. J Biol Chem, 272: 7617-25. doi: 10.1074/jbc.272.12.7617
    [10] Phung AD, Soucek K, Kubala L, et al. Posttranslational nitrotyrosination of alpha-tubulin induces cell cycle arrest and inhibits proliferation of vascular smooth muscle cells[J]. Eur J Cell Biol, 2006, 85(12): 1241-52. doi: 10.1016/j.ejcb.2006.05.016
    [11] Vattemi G, Mechref Y, Marini M, et al. Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement[M]. 2011: 002964.
    [12] 李雅东, 张劲松, 杨凯, 等. 微管蛋白酪氨酸连接酶类似物12通过干扰微管蛋白酪氨酸硝基化促进Hep-2细胞生长[J]. 中国生物化学与分子生物学报, 2012, 8: 728-32.
    [13] Kartha GK, Moshal KS, Sen U, et al. Renal mitochondrial damage and protein modification in type-2 diabetes[J]. Acta Diabetol, 2008, 45(2): 75-81. doi: 10.1007/s00592-008-0025-z
    [14] Yun B, Lee H, Ghosh M, et al. Serine hydrolase inhibitors block necrotic cell death by preventing Calcium overload of the mitochondria and permeability transition pore formation[J]. J Biol Chem, 2014, 289(3): 1491-504. doi: 10.1074/jbc.M113.497651
    [15] Brookes PS, Darley-Usmar VM. Role of Calcium and superoxide dismutase in sensitizing mitochondria to peroxynitrite-induced permeability transition[J]. Am J Physiol Heart Circ Physiol, 2004, 286(1): H39-46. http://d.scholar.cnki.net/detail/SJPD2059_U/SJPD12102401427144
    [16] 李菁, 景亮, 廖丽君, 等. 3-硝基酪氨酸对大鼠血管平滑肌细胞肾上腺素能受体α1D mRNA表达的影响[J]. 中华麻醉学杂志, 2005, 25(1): 40-2.
    [17] 景亮, 李菁, 赵纲, 等. 硝基酪氨酸对大鼠α-肾上腺素能受体介导血管反应性的影响[J]. 中华麻醉学杂志, 2004, 24(12): 913-5. http://d.wanfangdata.com.cn/Periodical/zhmzxzz98200412008
    [18] Murata M, Kawanishi S. Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation[J]. Biochem Biophys Res Commun, 2004, 316(1): 123-8. doi: 10.1016/j.bbrc.2004.02.022
    [19] Mu H, Wang X, Lin P, et al. Nitrotyrosine promotes human aortic smooth muscle cell migration through oxidative stress and ERK1/2 activation[J]. Biochim Biophys Acta, 2008, 1783(9): 1576-84. doi: 10.1016/j.bbamcr.2008.04.004
    [20] Xu ZZ, Wang M, Wang YJ, et al. Effect of nitrotyrosine on renal expressions of NF-kappaB, MCP-1 and TGF-beta1 in rats with diabetic nephropathy[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2013, 33: 346-50.
    [21] Julius U, Drel VR, Grässler J, et al. Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy[J]. Exp Clin Endocrinol Diabetes, 2009, 117(2): 72-7. doi: 10.1055/s-2008-1078710
    [22] Shao N, Kuang HY, Wang N, et al. Relationship between Oxidant/Antioxidant Markers and Severity of Microalbuminuria in the Early Stage of Nephropathy in Type 2 Diabetic Patients[Z]. 2013: 232404.
    [23] Lee W, Wang C, Lee H. Antioxidants in decelerating diabetic nephropathy[Z]. 2013.
    [24] Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications[J]. Circ Res, 2010, 106(8): 1319-31. doi: 10.1161/CIRCRESAHA.110.217117
    [25] Ceriello A, Quagliaro L, D'amico M, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat[J]. Diabetes, 2002, 51(4): 1076-82. doi: 10.2337/diabetes.51.4.1076
  • 加载中
计量
  • 文章访问数:  518
  • HTML全文浏览量:  233
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-06-24
  • 刊出日期:  2014-10-01

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日